Free scoping read. A written assessment of your manuscript in two business days, at no cost.

Start one
Contents

Academy · Research Writing · article from protocol

Preparing a Journal Article From a Study Protocol: Protocol Papers, Results Articles and Deviation Reporting

A study protocol gives rise to two distinct articles: the protocol paper, published before results exist, and the results article, which reports against what the protocol fixed in advance. Conflation of the two is the principal source of difficulty. This article examines which of the protocol standard’s minimum items belong in each document and what authors must disclose when a study departed from its plan. SPIRIT 2025 provides a 34-item checklist for reporting randomised trial protocols.

Pubrica AcademyWritten by the medical writing and biostatistics teams Reviewed byPubrica biostatistics team Published9 October 2026 Last checked9 October 2026 Reading time13 minutes Sources35 peer-reviewed

A protocol is not a draft of a paper but a commitment made before the data existed, and its value in the eventual article lies precisely in its having been written without knowledge of the result. The protocol-to-article step is therefore an exercise in disciplined reporting rather than rewriting: one primary objective and up to about five secondary objectives were fixed in advance, and the article must report against them regardless of whether they proved to be of greatest interest. The principal difficulties of the task follow from this constraint.

Learning objectives

  • The difference between a protocol paper and a results article, and when each is written
  • How the protocol items map onto the sections of a manuscript
  • How to report against pre-specified objectives when the most notable finding lies elsewhere
  • How to write a protocol-deviation statement that strengthens rather than weakens the paper
  • Which elements must carry across unchanged — registration, funding, ethics and acknowledgement
  • Which protocol text may be reused, and which forms of reuse constitute duplication

Common misconceptions

  • “The protocol is the first draft of the paper.” A protocol is a pre-commitment written without knowledge of the result, and its evidential value derives from that fact. Revising it in light of the findings removes the property that made it useful.
  • “A protocol paper and a results paper are the same document at different times.” The two documents have different audiences and functions. The protocol paper allows others to see what was planned before the outcome was known; the results article reports against that plan.
  • “If the secondary outcome is more interesting, lead with it.” The protocol fixed one primary and up to about five secondary objectives, and the article must report against them. Promoting a secondary finding to the headline without disclosure is the mechanism by which selective outcome reporting occurs.
  • “Deviations from protocol are best left unmentioned.” A declared deviation, reported with its reason and date, indicates competent conduct. An undeclared deviation, later identified by comparison of the registry entry with the published paper, constitutes a considerably more serious problem.
  • “Protocol text can be reused freely in the paper.” Methods text can, and generally should, be consistent. Wholesale reuse of the text of a published protocol paper in the results article constitutes duplication, which journals do check.

Distinction between the protocol paper and the results article

The protocol paper is published before results exist. Its purpose is to put the plan on the public record in more detail than a registry entry allows: the rationale, the design, the eligibility criteria, the outcome definitions, the analysis plan, the governance 22,28. Its readers are other researchers considering a similar study, reviewers who will later assess the results paper, and any reader wishing to establish what was planned before the outcome was known. It makes no claims about findings and should contain no results.

The results article reports what the study found, against what the protocol said it would look for. Its methods section is substantially the protocol’s methods, compressed; its results section reports the pre-specified outcomes in the pre-specified order; and it carries a statement of any deviation from the plan.

A third document underlies both in regulated research: the clinical study report, which is a different genre with its own structure and audience. The pages on protocol development and clinical study reporting cover those, and regulatory writing covers the submission documents.

Clarity about which article is being written matters because the two have opposite relationships to time. The protocol paper must be submitted before or early in recruitment to be meaningful; a protocol paper published after the results are known is an anomalous document, and some journals will not accept one. The results article cannot be written until the analysis is complete. The decision at the outset whether to publish a protocol paper is therefore a matter of scheduling rather than an afterthought.

Protocol paper and results article compared

Protocol paperResults article
When writtenBefore or early in recruitment; later publication is anomalous and some journals decline itAfter the analysis is complete
PurposePut the plan on record in more detail than a registry entry allowsReport findings against the plan
Contains results?NoYes, in the pre-specified order
Reporting standardThe protocol standard — 34 items in SPIRIT 2025The standard for the design: trial, observational or review guideline
ReadersResearchers planning similar work; later reviewers of the results paperAnyone interpreting or applying the finding
Discussion sectionLimited — no findings to interpretThe article’s own contribution, with no protocol antecedent
Relationship to the otherCited by the results article for full methodological detailMust be substantively consistent with it, and must not reproduce its text

Comparison of the two article types derived from a study protocol.

Origin of the SPIRIT 2013 minimum protocol items

The original SPIRIT 2013 protocol reporting standard defined 33 minimum items 28. The derivation of that number indicates what kind of list it is: the 33 items were distilled from a 59-item preliminary list through a three-round Delphi process with 96 expert panellists, drawing on 115 stakeholders in total 28.

Two implications follow. First, the list is a floor rather than a template: it is the minimum content a protocol must specify, reduced from a longer candidate set precisely so that it would be usable. Items were dropped because they were not minimally necessary, not because they are unimportant. Second, the list is consensus-derived, which means it encodes what a broad group of methodologists, editors, funders and trialists agreed a reader needs 28. That constitutes a reasonable authority but not an absolute one; a specific study may need to specify matters that the minimum items do not mention. SPIRIT 2025 provides a 34-item checklist for reporting randomised trial protocols.

For the writing task, the 34 SPIRIT 2025 items are best treated as the inventory of material already available. Protocol writing itself is given a dedicated 22-page chapter in a standard medical writing reference, which indicates how much structured content a complete protocol contains 22. The article-preparation task is therefore concerned less with generating text than with selection, compression and placement, which is a more tractable problem than most authors anticipate. The SPIRIT checklist lists the items themselves.

33minimum protocol items in SPIRIT 2013
59items on the preliminary list they were distilled from
96expert panellists across three Delphi rounds
115stakeholders involved in total

How the protocol standard was built. The 33 items of SPIRIT 2013 were a consensus-derived floor reduced from a longer candidate set so that the list would be usable — items were dropped for not being minimally necessary, not for being unimportant.

Mapping protocol items onto manuscript sections

Most protocol content has a determinate destination in a results article, and performing the mapping explicitly is faster and considerably less error-prone than writing from scratch.

Items about the rationale and background are condensed into the introduction, substantially so, because a protocol can accommodate a full justification and a paper cannot. Items about objectives are placed at the end of the introduction as the stated aim and then determine the order of the results. Items about design, eligibility, interventions, outcomes, allocation, blinding, data collection and analysis become the methods section, in roughly that order, with the outcome definitions reproduced exactly rather than paraphrased. Items about monitoring, harms and auditing are reported in the methods and then in the results where there is something to report. Items about ethics approval, consent, confidentiality, declaration of interests, access to data and dissemination are placed in the statements at the end of the article. Items about registration and the protocol version are reported in the methods and the article’s metadata.

Two mapping rules are more important than the others. Outcome definitions should be transcribed, not rewritten: a paraphrase that subtly alters a definition is indistinguishable, to a careful reader, from a changed outcome. Similarly, the analysis plan as stated in the protocol should appear in the methods in the form in which it was fixed, with any later addition clearly marked as post hoc 28. Our page on the structure of a medical paper covers the destination sections, and statistical analysis plan support covers the analysis item specifically.

Where protocol content goes in the results article

Protocol contentDestination in the articleTreatment
Background and rationaleIntroductionSubstantially condensed; a protocol can accommodate a full justification, a paper cannot
Objectives, primary and secondaryEnd of introduction, then the order of the resultsReproduced, and used as the results skeleton before any findings are examined
Design, eligibility, interventionsMethodsCompressed, with the protocol paper or registry cited for full detail
Outcome definitionsMethodsTranscribed exactly, not paraphrased — a subtle paraphrase is indistinguishable from a changed outcome
Allocation, blinding, data collectionMethodsCompressed; report what was done, not what was specified, where these differ
Analysis plan and sample sizeMethodsStated in the form it was fixed in; anything added later marked post hoc
Monitoring, harms, auditingMethods, then results where there is something to reportHarms reported whether or not any occurred
Ethics approval and consentEnd statementsVerified against the current approval, including amendments
Funding source and funder roleEnd statementsCarried across; good clinical practice requires it to travel from protocol to article
Declaration of interestsEnd statementsRefreshed for every author at submission, not copied
Dissemination and data accessEnd statementsCannot be more permissive in the article than the consent allowed
Registration and protocol versionMethods and article metadataIdentifier, registry and the version the study actually followed
—DiscussionThe only section with no protocol antecedent, and therefore where the writing effort belongs

Mapping built against the 33 minimum protocol items of SPIRIT 2013, which were distilled from a 59-item preliminary list through a three-round Delphi with 96 expert panellists and 115 stakeholders in total. Funding declaration and acknowledgement carry across under good clinical practice guidelines.

Reporting against pre-specified objectives

A protocol fixes one primary and up to about five secondary objectives in advance, and the article must then report against them 19,28. At this point protocol-derived writing demands particular discipline, because studies frequently produce their most notable result in an outcome other than the primary one.

The rule is simple, although the temptation to depart from it is strong. The primary outcome is reported first, with its pre-specified analysis, whatever it shows. The secondary outcomes are reported in the order the protocol listed them. Any further analyses are then reported and labelled accordingly: exploratory, post hoc, unplanned or hypothesis-generating. Such labelling is not a confession; it is information the reader needs to weight the finding correctly, and a paper that supplies it is more credible than one that does not, including with respect to its primary result.

The most difficult case is a null primary outcome accompanied by a striking secondary finding. The transparent approach reports the null primary outcome as the study’s answer to its question, reports the secondary finding with its pre-specified status, notes the multiplicity, and treats it as a hypothesis for a subsequent study. This produces a less striking but more durable paper. The misleading alternative, restructuring the article around the secondary finding, is detectable by any reader who consults the registry entry or the published protocol, which is precisely why the protocol paper exists.

As a practical measure, the results section should be drafted in the protocol’s order before the findings are examined for interest; the discipline is considerably easier to maintain once this skeleton is in place. The page on mandatory publication of clinical trials covers the surrounding obligations.

Function of the protocol-deviation statement

Few studies proceed exactly as planned. Recruitment falls behind schedule and the sample size is revised; an outcome measure proves unusable and is substituted; a site withdraws; a planned subgroup analysis becomes impossible because the subgroup did not recruit; a pandemic or a supply interruption alters the schedule. Such changes are common, and none of them undermines a paper when they are reported properly.

A well-constructed deviation statement has four components for each deviation: what changed, when, why, and whether the change was made before or after any outcome data were examined. The last component is the one most often omitted by authors and most needed by readers, because a change made without knowledge of the results is a practical adaptation, whereas a change made after the results were examined has different implications for interpretation.

The statement should be presented as a short list in the methods, with a cross-reference from the limitations. Where the deviation affects interpretation (for example, a revised sample size that reduced power, or a substituted outcome measure with different properties), the statement should specify what is affected rather than leaving this to the reader. Where a protocol amendment was made formally, its date and version should be given, because these are verifiable.

The case for complete reporting is not solely ethical. A clear deviation statement pre-empts the situation in which a reviewer compares the registry entry with the manuscript and identifies an unexplained difference, a sequence that tends to produce the most difficult review correspondence. The page on ICMJE guidance and trial registration support cover the registry side.

The statement of changes from the protocol

Silence, or a sentence that explains nothing

The study was conducted in accordance with the approved protocol. Minor amendments were made during the course of the study in response to practical considerations. The sample size was revised following a review of recruitment.

“In accordance with the approved protocol” is contradicted by the next two sentences. A reader cannot tell whether the study followed the plan or not.

“Minor amendments” characterises the changes instead of reporting them. “Minor” is the author’s judgement on a matter the reader is entitled to assess independently.

No dates and no versions, so nothing can be verified against the registry entry or the published protocol, which is where a reviewer will look.

“Revised following a review of recruitment” does not say whether outcome data had been seen. This is the most interpretively important fact about any change, and it is absent.

The consequence of the sample size change is not stated. A reduced target changes what the study could detect, and the limitations section is silent.

No statement that nothing else changed, so the reader cannot bound the uncertainty, and any unreported difference identified later appears to be concealment rather than omission.

A deviation log a reviewer can check

Three changes were made to the protocol as registered (version [n], [date]); all were formalised as amendments and the dates and versions are given below. First, the target sample size was reduced from [n] to [n] in protocol version [n] ([date]), following a recruitment review at [time point]. The reduction was agreed before any outcome data were examined, on the basis of accrual alone, and is reflected in the revised registry entry; it reduces the detectable difference the study was powered for, which we state in the limitations. Second, [outcome measure] was substituted for [original measure] in version [n] ([date]) because the original instrument was withdrawn by its publisher during the study; the substitution was made before any outcome data were examined, the two measures are not interchangeable, and we report the primary analysis using the substituted measure for all participants and a sensitivity analysis restricted to those assessed with the original. Third, the planned subgroup analysis by [characteristic] was not performed, because only [n] participants fell into one stratum; this decision was taken after the recruitment was closed but before the outcome analysis was run. No other changes were made to the eligibility criteria, the outcome definitions, the randomisation procedure or the pre-specified analysis plan. Analyses not pre-specified in any protocol version are identified as post hoc at each point they appear.

Each change is reported with what, when, why and whether outcome data had been examined — the four components a reader needs to weight it.

Versions and dates make every claim verifiable against the registry and the protocol, which pre-empts the discovery of a discrepancy by a reviewer.

The interpretive consequence of each change is stated, including the one that reduced the detectable difference, and is cross-referenced to the limitations.

The outcome substitution is handled analytically as well as narratively, with a sensitivity analysis, which demonstrates that the problem was addressed rather than merely disclosed.

An explicit statement that nothing else changed bounds the reader’s uncertainty, and makes the disclosure complete rather than partial.

Post hoc analyses are labelled wherever they appear, which protects the credibility of the pre-specified ones.

The protocol’s evidential value derives entirely from its having been written before the results were known. A deviation statement that records what changed and when, and especially whether outcome data had been seen, preserves that value. A statement that characterises changes as minor discards it and invites precisely the comparison with the registry entry that the author would least wish to prompt.

Elements carried unchanged from protocol to article

Some protocol content is not compressed, rewritten or selected. It is carried across, and the requirement comes from good clinical practice rather than from stylistic preference: funding source declaration and acknowledgement follow good clinical practice guidelines and must carry from the protocol through to the published article 12.

The elements carried across unchanged are the funding source and the role of the funder, including whether the funder had any part in design, analysis, interpretation or the decision to publish. The trial or study registration identifier and the registry. The ethics approval body and reference. The consent arrangement as approved. Declarations of interest for every author. Acknowledgement of contributors who are not authors, including those who performed recruitment, data management and laboratory analysis, who are routinely omitted; and the data availability arrangement as it was approved, which cannot be more permissive in the paper than the consent allowed.

The most common failure here concerns record-keeping rather than ethics: the author list changed over a multi-year study, the funding was supplemented by a second award, the ethics approval was amended, and the paper reproduces the protocol’s original statements. The carry-over set should be built as a checked list rather than copied from an earlier draft, and each entry should be verified against the current source document.

A second failure worth naming: acknowledgement is where a long study’s contributors accumulate, and reconstructing it at submission from memory reliably omits people. Keep the acknowledgement list as a living file from the protocol onward.

Reuse of protocol text and the avoidance of duplication

Where a protocol paper has been published, the results article carries a specific hazard: the two documents share methods, and the overlap can amount to duplication. The appropriate position is that consistency of substance is required and identity of text is not.

What should be consistent: outcome definitions, eligibility criteria, the analysis plan, the design description. A reader comparing the two documents should find no substantive difference, and where there is one, the deviation statement explains it.

What should not be identical: the prose. A results article’s methods section is a compression written for a reader who wants to interpret findings, not a specification written for a reader who wants to run the study. Rewriting it is not merely a duplication precaution; it produces a better methods section, because the two audiences need different levels of detail.

Three practical rules apply. The protocol paper should be cited in the methods with a statement that full details are available there; this is the correct solution to the compression problem and the purpose the protocol paper serves. The introduction of the protocol paper should not be reproduced, since this is where overlap is both most tempting and least defensible. Finally, the prior publication should be disclosed in the cover letter, which removes any question of concealment. The pages on duplicate publication and identifying multiple publication set out where the boundaries lie, and similarity checking is where overlap gets measured before a journal does it.

Applicable reporting standards at each stage

Protocols and results articles are reported to different standards, and using the wrong one produces a document missing the items its readers need.

The protocol and the protocol paper are reported to the protocol standard, now the 34-item SPIRIT 2025 checklist 28. The results article is reported to the standard for its design: a randomised trial to the trial reporting guideline, an observational study to the observational one, a systematic review to the review guideline. These are not alternatives to the protocol standard but its downstream counterparts, and the items correspond in a way that makes the protocol-to-article mapping straightforward when both are used.

Two practical points follow. The results-stage checklist should be completed during drafting rather than at submission, because several of its items require decisions that must have been made earlier, and an item found to be unanswerable at submission represents a gap that can no longer be filled. Where a protocol was registered but no protocol paper was published, the registry entry should be cited in the methods together with the protocol version the study followed; this gives the reader the same ability to compare plan with report.

Our pages on the CONSORT checklist, STROBE for observational studies and PRISMA for reviews cover the results-stage standards, and reporting checklist review is where we map a draft against the right one.

Sequence of the protocol-to-article workflow

The most efficient sequence is as follows. The protocol and the registry entry are opened side by side. The skeleton of the results article is built from the protocol’s objectives, in the protocol’s order, before any findings are examined. The outcome definitions are transcribed exactly. The protocol’s methods are condensed into a methods section, citing the protocol paper or registry for full detail. The deviation log is built by comparing what happened with what was planned, item by item, with dates and an indication of whether each change was made blind to the outcome data. The carry-over set (funding, registration, ethics, consent, interests, acknowledgement, data availability) is assembled by verifying each element against its current source document rather than copying an earlier draft. The results are then entered in the skeleton’s order, followed by the discussion, which is the only section with no protocol antecedent. The reporting checklist for the design is completed next, then the abstract, and finally the title.

This order offers two advantages. The results section is built in the pre-specified order before it is known which finding is of interest, which is the most effective guard against selective reporting. The deviation log is built by comparison rather than recollection, which is the only way to ensure that it is complete.

One element of content cannot be supplied by the protocol. The ten key ingredients identified for a health research proposal, rated for importance by nine experts, describe the content a protocol-derived article must be able to report, and the one with no protocol antecedent is the interpretation 31. A protocol can specify what will be measured and how it will be analysed; it cannot specify what the finding will mean. That is the article’s own contribution, and it is where the writing effort should be concentrated. See our page on writing and publishing an original research article.

Key points

Key points

A protocol yields two distinct articles that should not be confused: the protocol paper, which places the plan on record before results exist and reports to the minimum items of the protocol standard (34 in SPIRIT 2025), and the results article, which reports findings against that plan under the reporting guideline for its design. The skeleton of the results article should be built from the protocol’s objectives — one primary and up to about five secondary — in the protocol’s order, before the findings are examined, because this practice is the most effective safeguard against selective reporting. Outcome definitions should be transcribed rather than paraphrased. Every deviation should be reported with what changed, when, why and whether outcome data had been examined, together with a statement that nothing else changed. The funding declaration, registration, ethics approval, consent arrangement, interests, acknowledgement and data availability should be carried across unchanged and verified against current sources rather than an earlier draft. The protocol cannot supply the interpretation, which remains the article’s own contribution.

Application to your study

Application to your study

  1. Determine at the outset whether a protocol paper will be published. A protocol paper must be submitted before or early in recruitment to be meaningful, so this is a scheduling decision rather than an afterthought.
  2. Build the results skeleton from the protocol’s objectives before examining the findings. The primary objective comes first, followed by the secondary objectives in the protocol’s order; the skeleton is completed afterwards.
  3. Transcribe outcome definitions exactly. A paraphrase that shifts a definition is indistinguishable, to a careful reader, from a changed outcome.
  4. Construct the deviation log by systematic comparison rather than recollection. The protocol should be compared item by item with the conduct of the study, recording what changed, when, why and whether outcome data had been seen.
  5. State explicitly that nothing else changed. This bounds the reader’s uncertainty and is what distinguishes a complete disclosure from a partial one.
  6. Label every unplanned analysis as post hoc at each point it appears. It protects the credibility of the pre-specified analyses rather than undermining the paper.
  7. Verify the carry-over set against current source documents. Funding and funder role, registration, ethics approval including amendments, consent, every author’s interests, acknowledgement, data availability.
  8. Cite the protocol paper or registry entry for methodological detail, and rewrite the prose. Consistency of substance is required; identical text constitutes duplication.
  9. Complete the design’s reporting checklist during drafting, not at submission. Several items require decisions that had to be made earlier, and an item that cannot be answered at submission represents a gap that can no longer be filled.

Frequently asked questions

The two differ in purpose, timing and reporting standard. A protocol paper is published before results exist, to place the plan on the public record in more detail than a registry entry allows: rationale, design, eligibility, outcome definitions, analysis plan and governance. It contains no results, and it must appear before or early in recruitment to be meaningful; some journals decline a protocol paper submitted once the study is complete. A results article reports the findings against that plan, with a methods section that condenses the protocol’s and results presented in the pre-specified order. The protocol paper is reported to the protocol standard’s 34 items (SPIRIT 2025); the results article to the guideline for its design, whether trial, observational or review.

The task is best treated as selection, compression and placement rather than as writing. The protocol and the registry entry are opened together, and the results skeleton is built from the protocol’s objectives, in the protocol’s order, before any findings are examined. The outcome definitions are transcribed exactly. The protocol’s methods are condensed for a reader who wishes to interpret findings rather than run the study, citing the protocol paper or registry for full detail. The deviation log is built by comparing the protocol, item by item, with what happened. The carry-over set (funding, registration, ethics, consent, interests, acknowledgement, data availability) is assembled by verifying each element against its current source. The results are then completed, followed by the discussion, which is the only section with no protocol antecedent and where the principal writing effort belongs.

The primary outcome should still be reported first, with its pre-specified analysis, whatever it shows; then the secondary outcomes in the protocol’s order; then any further analyses, explicitly labelled exploratory or post hoc. The protocol fixed one primary and up to about five secondary objectives in advance, and the article’s function is to report against them. The transparent treatment of a null primary outcome with a striking secondary finding is to present the null result as the study’s answer to its question, present the secondary finding with its pre-specified status, note the multiplicity, and treat it as a hypothesis for a further study. This produces a less striking but more durable paper. Restructuring the article around the secondary finding is detectable by any reader who consults the registry entry, which is partly why protocols are registered.

It should be presented as a short, dated list in the methods, with four components for each deviation: what changed, when, why, and whether the change was made before or after any outcome data were examined. The last component is the one most often omitted by authors and most needed by readers, because a change made without knowledge of the results is a practical adaptation, whereas one made after the results were examined carries different interpretive implications. Protocol versions and amendment dates should be given so that each item can be verified against the registry. The interpretive consequence should be stated where there is one; a reduced sample size, for example, changes what the study could detect. An explicit sentence stating that nothing else changed should also be included, which bounds the reader’s uncertainty and makes the disclosure complete rather than partial.

Funding source declaration and acknowledgement carry from protocol to published article under good clinical practice guidelines, and in practice the set carried across is wider: the funding source and the funder’s role including any part in design, analysis, interpretation or the decision to publish; the registration identifier and registry; the ethics approval body and reference; the consent arrangement as approved; declarations of interest for every author; acknowledgement of non-author contributors; and the data availability arrangement, which cannot be more permissive in the paper than the consent allowed. The most common failure concerns record-keeping rather than ethics: author lists, funding and approvals all change over a multi-year study, and the paper reproduces the protocol’s original statements. Each entry should be verified against its current source document.

Consistency of substance is required; identity of text is not, and wholesale reuse raises a duplication concern that journals do check. Outcome definitions, eligibility criteria, the analysis plan and the design description must be substantively the same, with any difference explained in the deviation statement. The prose should be rewritten, which is not only a precaution: a results article’s methods section is written for a reader interpreting findings, whereas a protocol paper’s is written for a reader who might run the study, and the two require different levels of detail. Three practical rules apply: cite the protocol paper in the methods and refer to it for full detail, do not reproduce its introduction, and disclose the prior publication in the cover letter.

It is a floor, not a template. The 33 minimum items of SPIRIT 2013 were distilled from a 59-item preliminary list through a three-round Delphi process with 96 expert panellists, drawing on 115 stakeholders in total, so the list was deliberately reduced to what is minimally necessary in order to be usable. SPIRIT 2025 provides a 34-item checklist for reporting randomised trial protocols. Items were dropped for not being minimally necessary, not for being unimportant, which means a particular study may need to specify matters the minimum items do not mention. It is also consensus-derived rather than deduced, encoding what a broad group of methodologists, editors, funders and trialists agreed a reader needs. For the writing task, it is best treated as the inventory of material a complete protocol already contains, which makes article preparation a problem of placement rather than generation.

Two different standards apply at two stages, and they are complementary rather than alternative. The protocol and any protocol paper are reported to the protocol standard — the 34 items of SPIRIT 2025. The results article is reported to the guideline for its design: the trial guideline for a randomised trial, the observational guideline for a cohort or case-control study, the review guideline for a systematic review. Because the item sets correspond, using both makes the protocol-to-article mapping straightforward. Two practical points apply: the results-stage checklist should be completed while drafting rather than at submission, since several items ask for decisions that had to be made earlier; and where a protocol was registered but never published as a paper, the registry entry should be cited together with the protocol version the study actually followed.

References

  1. Hesselberg JO, Ulleberg P, Sorensen O, et al. Registered report protocol: Factors associated with inter-rater agreement in grant peer review. PLOS ONE. 2025;20(5):e0322696. doi:10.1371/journal.pone.0322696 read 9 October 2026. doi.org/10.1371/journal.pone.0322696
  2. Willis LD. Formulating the Research Question and Framing the Hypothesis. Respiratory Care. 2024;69(4). doi:10.4187/respcare.10975 read 9 October 2026. doi.org/10.4187/respcare.10975
  3. Agreement and MOU: Ethical and Legal Aspects of Funding for Healthcare Research. Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:103-116. doi:10.1007/978-981-19-7018-4_9 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_9
  4. Patil SG. Budgeting the Project: Detailing the Required Funding and Expenditure. Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:77-91. doi:10.1007/978-981-19-7018-4_7 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_7
  5. Rajappa M. Checklist for Grant Proposal: Mandatory Elements. Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:161-165. doi:10.1007/978-981-19-7018-4_14 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_14
  6. Joshi M, Joshi P, Smith JA. Dealing with the Rejected Grant Proposal: Learning from the Mistakes. Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:179-187. doi:10.1007/978-981-19-7018-4_16 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_16
  7. Rahi M, Sharma S, Yadav B. Funders' Perspective: What the Funding Body Expects from Researchers? Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:21-31. doi:10.1007/978-981-19-7018-4_3 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_3
  8. Dubashi B, Ramadass B. Funding Organizations for Science and Health Care. Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:33-52. doi:10.1007/978-981-19-7018-4_4 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_4
  9. Parija SC, Kate V (eds). Grant writing for medical and healthcare professionals. Springer, Singapore. 2023. doi:10.1007/978-981-19-7018-4 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4
  10. Weidmann AE, Cadogan CA, Fialova D, et al. How to write a successful grant application: guidance provided by the European Society of Clinical Pharmacy. International Journal of Clinical Pharmacy. 2023;45(3):781-786. doi:10.1007/s11096-023-01543-7 read 9 October 2026. doi.org/10.1007/s11096-023-01543-7
  11. Tamblyn R, Girard N, Hanley J, et al. Ranking versus rating in peer review of research grant applications. PLOS ONE. 2023;18(10):e0292306. doi:10.1371/journal.pone.0292306 read 9 October 2026. doi.org/10.1371/journal.pone.0292306
  12. Subramanian K, Muthuramalingam A, Chandrasekaran V. Sources of Funding and Acknowledgement: Good Clinical Practice Guidelines. Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:145-152. doi:10.1007/978-981-19-7018-4_12 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_12
  13. Surveillance Plan and Site Visit: Roles and Rights of the Researcher and the Funding Agency. Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:133-144. doi:10.1007/978-981-19-7018-4_11 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_11
  14. Nachiappa Ganesh R. Tips for Improvising the Chance of Getting the Grant. Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:167-177. doi:10.1007/978-981-19-7018-4_15 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_15
  15. Parija SC, Shrivastava SR. What Is Your Aim (Ambition-Interest-Mission), and What You Want to Do? Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:3-12. doi:10.1007/978-981-19-7018-4_1 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_1
  16. What Is a Grant? How to Prepare a Grant Proposal Application. Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:13-20. doi:10.1007/978-981-19-7018-4_2 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_2
  17. Kate V, Gupta D, Balakrishnan G. Writing a Grant Proposal for a Single Centre Study: Step-by-Step Approach. Grant writing for medical and healthcare professionals (Parija SC, Kate V, eds), Springer, Singapore. 2023:63-76. doi:10.1007/978-981-19-7018-4_6 read 9 October 2026. doi.org/10.1007/978-981-19-7018-4_6
  18. Monavarian M. Basics of scientific and technical writing: Grant proposals. MRS Bulletin. 2021;46(5):455-457. doi:10.1557/s43577-021-00105-4 read 9 October 2026. doi.org/10.1557/s43577-021-00105-4
  19. Dhir SK, Gupta P. Formulation of Research Question and Composing Study Outcomes and Objectives. Indian Pediatrics. 2021;58:584-588. read 9 October 2026. indianpediatrics.net
  20. Kan P, Mokin M, Mack WJ, et al. Strategies for writing a successful National Institutes of Health grant proposal for the early-career neurointerventionalist. Journal of NeuroInterventional Surgery. 2020. doi:10.1136/neurintsurg-2020-016964 read 9 October 2026. doi.org/10.1136/neurintsurg-2020-016964
  21. Moller R, Shoshan M. Does reality meet expectations? An analysis of medical students' expectations and perceived learning during mandatory research projects. BMC Medical Education. 2019;19:93. doi:10.1186/s12909-019-1526-x read 9 October 2026. doi.org/10.1186/s12909-019-1526-x
  22. Taylor RB. How to Write a Research Protocol. Medical Writing (Springer, Cham). 2018:239-260. doi:10.1007/978-3-319-70126-4_9 read 9 October 2026. doi.org/10.1007/978-3-319-70126-4_9
  23. Shepherd J, Frampton GK, Pickett K, et al. Peer review of health research funding proposals: A systematic map and systematic review of innovations for effectiveness and efficiency. PLoS ONE. 2018;13(5):e0196914. doi:10.1371/journal.pone.0196914 read 9 October 2026. doi.org/10.1371/journal.pone.0196914
  24. Boyack KW, Smith C, Klavans R. Toward predicting research proposal success. Scientometrics. 2018;114(2):449-461. doi:10.1007/s11192-017-2609-2 read 9 October 2026. doi.org/10.1007/s11192-017-2609-2
  25. Dey SK, Gerhardt K. How to Write a Competitive R01 Grant. Springer, Cham. 2016. doi:10.1007/978-3-319-41360-0 read 9 October 2026. doi.org/10.1007/978-3-319-41360-0
  26. Agency for Healthcare Research and Quality. Common Problems Identified During Peer Review. Agency for Healthcare Research and Quality (AHRQ). 2014. read 9 October 2026. ahrq.gov
  27. Herbert DL, Barnett AG, Clarke P, Graves N. On the time spent preparing grant proposals: an observational study of Australian researchers. BMJ Open. 2013;3(5):e002800. doi:10.1136/bmjopen-2013-002800 read 9 October 2026. doi.org/10.1136/bmjopen-2013-002800
  28. Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials. Annals of Internal Medicine. 2013;158(3):200-207. doi:10.7326/0003-4819-158-3-201302050-00583 read 9 October 2026. doi.org/10.7326/0003-4819-158-3-201302050-00583
  29. Abdoul H, Perrey C, Amiel P, et al. Peer Review of Grant Applications: Criteria Used and Qualitative Study of Reviewer Practices. PLoS ONE. 2012;7(9):e46054. doi:10.1371/journal.pone.0046054 read 9 October 2026. doi.org/10.1371/journal.pone.0046054
  30. National Institute of Allergy and Infectious Diseases (NIAID). Strategy for NIH Funding: Ten Steps to a Winning R01 Application. National Institutes of Health (NIAID). 2012. read 9 October 2026. ipr.osu.edu
  31. Proctor EK, Powell BJ, Baumann AA, et al. Writing implementation research grant proposals: ten key ingredients. Implementation Science. 2012;7(1):96. doi:10.1186/1748-5908-7-96 read 9 October 2026. doi.org/10.1186/1748-5908-7-96
  32. Hollins Martin CJ, Fleming V. A 15-step model for writing a research proposal. British Journal of Midwifery. 2011;18:791-798. read 9 October 2026. napier-repository.worktribe.com
  33. Eve J. Writing a research proposal: planning and communicating your research ideas effectively. Library and Information Research. 2009;32(102):18-28. doi:10.29173/lirg92 read 9 October 2026. doi.org/10.29173/lirg92
  34. SUNY Geneseo Sponsored Research (adapted from Locke, Spirduso and Silverman, Proposals That Work, 2nd ed., Sage, 1987). Common Reasons Grant Proposals Are Rejected. SUNY Geneseo Office of Sponsored Research. read 9 October 2026. geneseo.edu
  35. National Institute of Mental Health. Grant Writing Assistance. National Institutes of Health (NIMH). read 9 October 2026. nimh.nih.gov

Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.

How to cite this article

Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.

Pubrica Academy. (2026, October 9). Preparing a Journal Article From a Study Protocol: Protocol Papers, Results Articles and Deviation Reporting. Pubrica. https://pubrica.com/academy/clinical-research-service/preparation-of-article-based-on-the-study-protocol/

This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.

Protocol-to-article mapping worksheet and deviation log

Three parts, to be completed in this order. Part 1 builds the results skeleton from the protocol before any findings are examined; this is the step that guards against selective reporting. Part 2 is the deviation log, built by comparison rather than recollection. Part 3 is the carry-over set, verified against current source documents.

PROTOCOL TO ARTICLE WORKSHEET

DOCUMENTS OPEN WHILE COMPLETING THIS
  Protocol, version ______  dated ______________
  Latest protocol version actually followed: ______  dated ________
  Registry entry: ______________  last updated ______________
  Published protocol paper, if any: ______________________
  Statistical analysis plan, version ______  dated ______________
  Ethics approval and amendments: ______________________


PART 1. RESULTS SKELETON  (build BEFORE examining any findings)

  PRIMARY OBJECTIVE, copied verbatim from the protocol:
    ____________________________________________
  Primary outcome, DEFINITION TRANSCRIBED EXACTLY:
    ____________________________________________
  Pre-specified analysis for it:
    ____________________________________________
  [ ] This is reported first in the results, whatever it shows

  SECONDARY OBJECTIVES, in the protocol's order:
    S1 ______________________  outcome definition: ______________
    S2 ______________________  outcome definition: ______________
    S3 ______________________  outcome definition: ______________
    S4 ______________________  outcome definition: ______________
    S5 ______________________  outcome definition: ______________
  [ ] Reported in this order, not in order of interest
  [ ] None omitted; any that could not be assessed is reported as such

  ANYTHING ELSE I WANT TO REPORT:
    E1 ______________________  pre-specified anywhere?  yes / no
    E2 ______________________  pre-specified anywhere?  yes / no
    E3 ______________________  pre-specified anywhere?  yes / no
  [ ] Each "no" is labelled POST HOC at every point it appears
  [ ] Multiplicity is addressed in the text

  HARMS OR ADVERSE EVENTS
  [ ] Reported whether or not any occurred


PART 2. DEVIATION LOG  (walk the protocol item by item)

  For EACH deviation:

  Deviation 1
    What changed: ______________________________
    From: ______________  To: ______________
    Protocol version that formalised it: ______  date: ____________
    Why: ______________________________
    Outcome data examined before this change?  YES / NO
       [ ] This is stated in the article
    Interpretive consequence: ______________________________
       [ ] Cross-referenced in the limitations
    Registry entry updated?  yes / no

  Deviation 2
    (same fields)

  Deviation 3
    (same fields)

  ITEM-BY-ITEM COMPARISON  (tick only after checking each)
    [ ] Eligibility criteria unchanged
    [ ] Recruitment setting and sites unchanged
    [ ] Intervention or exposure unchanged
    [ ] Comparator unchanged
    [ ] PRIMARY OUTCOME definition unchanged
    [ ] Primary outcome time point unchanged
    [ ] Secondary outcome definitions unchanged
    [ ] Randomisation or allocation procedure unchanged
    [ ] Blinding unchanged
    [ ] Sample size target unchanged
    [ ] Pre-specified analysis unchanged
    [ ] Subgroup analyses as planned
    [ ] Missing data approach as planned
    [ ] Monitoring arrangement unchanged

  CLOSING SENTENCE FOR THE ARTICLE:
    "No other changes were made to ______________________________."
    [ ] This sentence is in the manuscript


PART 3. CARRY-OVER SET  (verify each against its CURRENT source)

  Item                        Verified against          Date checked
  Funding source(s)           ______________________    __________
     [ ] All awards listed, including later supplements
     Funder role in design / analysis / interpretation / decision to
     publish: ______________________________
  Registration identifier     ______________________    __________
     Registry: ______________  [ ] entry matches the manuscript
  Ethics approval body        ______________________    __________
     Reference: ______________  Amendments: ______________
  Consent arrangement         ______________________    __________
     [ ] As approved; not described more broadly than approved
  Author list and order       ______________________    __________
     [ ] Current, not the protocol's original list
     [ ] Every author meets the authorship criteria applied
  Declarations of interest    ______________________    __________
     [ ] Refreshed for EVERY author at submission, not copied
  Acknowledgement             ______________________    __________
     [ ] Built from the living file kept since the protocol
     [ ] Includes recruitment, data management and laboratory staff
     [ ] Permission obtained from each named person
  Data availability           ______________________    __________
     [ ] Not more permissive than the consent allowed
  Protocol version cited      ______________________    __________


PART 4. OVERLAP AND DUPLICATION  (if a protocol paper was published)

  Protocol paper citation: ______________________________
  [ ] Cited in the methods, with "full details are reported in"
  [ ] Methods PROSE rewritten for an interpreting reader
  [ ] Substance identical: outcome definitions, eligibility, analysis
  [ ] Protocol paper's INTRODUCTION not reproduced
  [ ] Prior publication disclosed in the cover letter
  [ ] Similarity check run before submission


PART 5. REPORTING CHECKLIST  (complete DURING drafting)

  Design of this study: ______________________
  Results-stage guideline that applies: ______________________
  [ ] Checklist completed with section and page locations, not ticks
  Items I CANNOT answer, and why:
    ____________________________________________
    [ ] Each is an acknowledged limitation, not a silent gap


PART 6. WRITING ORDER  (the discussion is the only new content)

  [ ] 1. Skeleton built from protocol objectives
  [ ] 2. Outcome definitions transcribed
  [ ] 3. Methods compressed from protocol
  [ ] 4. Deviation log built by comparison
  [ ] 5. Carry-over set verified
  [ ] 6. Results filled into the skeleton
  [ ] 7. Discussion written  - the interpretation is the ARTICLE'S own
           contribution; the protocol cannot supply it
  [ ] 8. Reporting checklist completed
  [ ] 9. Abstract written
  [ ] 10. Title written last

Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.

How Pubrica can help

Pubrica maps a protocol onto a manuscript item by item: the results skeleton is built from the pre-specified objectives before the findings are examined, outcome definitions are transcribed rather than paraphrased, and the deviation log is constructed by comparing the protocol and registry entry with the conduct of the study. The carry-over set — funding, registration, ethics, consent, interests, acknowledgement and data availability — is verified against current source documents, and overlap with any published protocol paper is checked before submission.

Find something else

Search the Pubrica Academy

Access is free and requires no account. Enter a topic, or open the full library to filter by category, sub-topic or resource type.

Pubrica accepts the protocol, the registry entry and the draft manuscript, and returns an item-by-item mapping, a deviation log and an overlap check.

A scoping assessment is free and takes two business days. It provides a written assessment of what the work requires and which specialist would undertake it.

Get a free quote

Regulations

Check your project against this rule

  1. 1Your work
  2. 2Your details
  3. 3Send
What do you need?

Material you send is held under signed confidentiality, with access limited to the assigned team and encrypted transfer. It is not used to train anything and is not passed to third-party tools. Ask for the agreement before you send anything you would rather cover first.